Showing results (51-60 of 377) with videos related to
Sort By:
Pageof 38
Lancet (London, England)|December 14, 2002
Hot flushesVered Stearns, Lynda Ullmer, Juan F López, et al.Cancer Genetics and Cytogenetics|April 24, 2004
Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancerLuciane R Cavalli, Baljit Singh, Claudine Isaacs, et al.Oncology and Therapy|April 15, 2025
Oncotype DX Recurrence Score and Germline BRCA Variants in Patients with HR-Positive/HER2-Negative Early Breast Cancer: A Retrospective Observational StudyStefania Morganti, Rabia A Khan, Luis C Berrocal-Almanza, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 12, 2002
Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testingBeth N Peshkin, Marc D Schwartz, Claudine Isaacs, et al.Breast Cancer Research and Treatment|March 8, 2002
Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancerClaudine Isaacs, Beth N Peshkin, Marc Schwartz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sampleMarc D Schwartz, Beth N Peshkin, Chanita Hughes, et al.Cancer Control : Journal of the Moffitt Cancer Center|November 15, 2016
Genomic Disparities in Breast Cancer Among LatinasFilipa Lynce, Kristi D Graves, Lina Jandorf, et al.Cancer Medicine|December 17, 2021
Simulation modeling of breast cancer endocrine therapy duration by patient and tumor characteristicsYoung Chandler, Clyde Schechter, Jinani Jayasekera, et al.Clinical Breast Cancer|January 4, 2015
Patterns of 21-gene assay testing and chemotherapy use in black and white breast cancer patientsVanessa B Sheppard, Suzanne C O'Neill, Asma Dilawari, et al.Drugs|October 7, 2022
Emerging Targeted Therapies for Early Breast CancerIlana Schlam, Paolo Tarantino, Stefania Morganti, et al.Pageof 38